United Kingdom

People: Cardinal Health Inc (CAH.N)

CAH.N on New York Stock Exchange

19 Aug 2019
Change (% chg)

$0.29 (+0.67%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Cox, Carrie 

Ms. Carrie S. Cox serves as Independent Director of Cardinal Health Inc. Ms. Cox has served as Chief Executive Officer of Humacyte, Inc., a privately held, development stage company focused on regenerative medicine, since 2010 and as Chairman of Humacyte since 2013. From 2003 to 2009, she served as Executive Vice President and President of Global Pharmaceuticals at Schering-Plough Corporation, a multinational branded pharmaceutical manufacturer. Ms. Cox previously was Executive Vice President and President of Global Prescription Business of Pharmacia Corporation from 1997 to 2003. Through her roles as a former executive officer of Schering-Plough, President of Pharmacia's Global Prescription business and a licensed pharmacist, and now with Humacyte, Ms. Cox brings to the Board substantial expertise in healthcare, particularly the pharmaceutical and international aspects of our business. She has worked in the global pharmaceutical industry for over 30 years, giving her relevant experience with large, multinational pharmaceutical companies in the areas of operations, management, regulatory compliance, executive leadership, strategic planning and global markets. She also brings to the Board valuable perspective and insights from her service on the boards of directors of Texas Instruments, including its Compensation Committee and service as its Lead Director, and Celgene.

Basic Compensation

Total Annual Compensation, USD 100,000
Restricted Stock Award, USD 160,000
Long-Term Incentive Plans, USD --
All Other, USD 3,500
Fiscal Year Total, USD 263,500

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --